Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

Reports record-high revenues since inceptionMONTREAL, March 20, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

The Sussex RNA Research Centre was formally opened at the Sussex RNA Impact Day, which was held at the AMEX stadium on Monday ...

The impact of tariffs on this continuing trend has become a major ... beating its benchmark by 218 percentage points (see ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments, today ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

Swedish company Sigrid’s weight loss product Carb Fence has been recognised by the US Food and Drug Administration as a ...

Clinical hold lifted for late stage cadisegliatin program for diabetesCATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to ...

To access Vivos' investor conference call, please dial (800) 717-1738, or for international callers, (646) 307-1865. A replay will be available shortly after the call and can be accessed by dialing ...

CEO of Cognito Therapeutics. "The findings build on our previous research, showing that preserving brain connectivity and structure through non-invasive neuromodulation could significantly impact ...